GarcÃa-Vázquez, R.; Jørgensen, J.T.; Bratteby, K.E.; Shalgunov, V.; Hvass, L.; Herth, M.M.; Kjær, A.; Battisti, U.M.
Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging. Pharmaceuticals 2022, 15, 245.
https://doi.org/10.3390/ph15020245
AMA Style
GarcÃa-Vázquez R, Jørgensen JT, Bratteby KE, Shalgunov V, Hvass L, Herth MM, Kjær A, Battisti UM.
Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging. Pharmaceuticals. 2022; 15(2):245.
https://doi.org/10.3390/ph15020245
Chicago/Turabian Style
GarcÃa-Vázquez, RocÃo, Jesper Tranekjær Jørgensen, Klas Erik Bratteby, Vladimir Shalgunov, Lars Hvass, Matthias M. Herth, Andreas Kjær, and Umberto Maria Battisti.
2022. "Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging" Pharmaceuticals 15, no. 2: 245.
https://doi.org/10.3390/ph15020245
APA Style
GarcÃa-Vázquez, R., Jørgensen, J. T., Bratteby, K. E., Shalgunov, V., Hvass, L., Herth, M. M., Kjær, A., & Battisti, U. M.
(2022). Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging. Pharmaceuticals, 15(2), 245.
https://doi.org/10.3390/ph15020245